Avacta Group Plc (LON:AVCT – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 49 ($0.62) and last traded at GBX 49 ($0.62), with a volume of 4167502 shares changing hands. The stock had previously closed at GBX 50.90 ($0.64).
Avacta Group Price Performance
The company has a 50 day simple moving average of GBX 78.21 and a 200-day simple moving average of GBX 110.21. The stock has a market cap of £174.38 million, a price-to-earnings ratio of -310.94 and a beta of 1.21. The company has a current ratio of 0.71, a quick ratio of 4.96 and a debt-to-equity ratio of 225.41.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Recommended Stories
- Five stocks we like better than Avacta Group
- Quiet Period Expirations Explained
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Investing in Commodities: What Are They? How to Invest in Them
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is the Australian Securities Exchange (ASX)
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
